University College London: 'Gene Silencer' Drug Shows Promise in Treating Heart Condition
September 07, 2024
September 07, 2024
LONDON, England, Sept. 7 (TNSres) -- The University College London issued the following news:
* * *
A drug known as a "gene silencer" has shown promise in reducing hospitalisation and deaths from a devastating condition known as transthyretin (ATTR) cardiac amyloidosis, according to a new study led by UCL researchers.
* * *
The study, presented at the European Society of Cardiology (ESC) congress, with results simultaneously published . . .
* * *
A drug known as a "gene silencer" has shown promise in reducing hospitalisation and deaths from a devastating condition known as transthyretin (ATTR) cardiac amyloidosis, according to a new study led by UCL researchers.
* * *
The study, presented at the European Society of Cardiology (ESC) congress, with results simultaneously published . . .